1563 related articles for article (PubMed ID: 8863832)
21. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
22. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
[TBL] [Abstract][Full Text] [Related]
23. Distinct muscarinic receptors, G proteins and phospholipases in esophageal and lower esophageal sphincter circular muscle.
Sohn UD; Harnett KM; De Petris G; Behar J; Biancani P
J Pharmacol Exp Ther; 1993 Dec; 267(3):1205-14. PubMed ID: 8263781
[TBL] [Abstract][Full Text] [Related]
24. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C.
Liu M; Simon MI
Nature; 1996 Jul; 382(6586):83-7. PubMed ID: 8657310
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase C isoforms in vascular smooth muscle and their regulation by G-proteins.
Blayney LM; Gapper PW; Newby AC
Br J Pharmacol; 1996 Jun; 118(4):1003-11. PubMed ID: 8799575
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
Pobiner BF; Northup JK; Bauer PH; Fraser ED; Garrison JC
Mol Pharmacol; 1991 Aug; 40(2):156-67. PubMed ID: 1908548
[TBL] [Abstract][Full Text] [Related]
27. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor.
Murthy KS; Teng BQ; Zhou H; Jin JG; Grider JR; Makhlouf GM
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G974-80. PubMed ID: 10859228
[TBL] [Abstract][Full Text] [Related]
28. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
[TBL] [Abstract][Full Text] [Related]
29. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLC-beta3 via Gbetagammai3.
Murthy KS; Makhlouf GM
J Biol Chem; 1998 Feb; 273(8):4695-704. PubMed ID: 9468531
[TBL] [Abstract][Full Text] [Related]
31. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
32. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
[TBL] [Abstract][Full Text] [Related]
33. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
Seifert R; Hagelüken A; Höer A; Höer D; Grünbaum L; Offermanns S; Schwaner I; Zingel V; Schunack W; Schultz G
Mol Pharmacol; 1994 Apr; 45(4):578-86. PubMed ID: 7514261
[TBL] [Abstract][Full Text] [Related]
34. Agonist-independent, muscle-type-specific signal transduction pathways in cat esophageal and lower esophageal sphincter circular smooth muscle.
Sohn UD; Han B; Tashjian AH; Behar J; Biancani P
J Pharmacol Exp Ther; 1995 Apr; 273(1):482-91. PubMed ID: 7536246
[TBL] [Abstract][Full Text] [Related]
35. Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
Murthy KS; Grider JR; Makhlouf GM
J Pharmacol Exp Ther; 1992 Jan; 260(1):90-7. PubMed ID: 1309882
[TBL] [Abstract][Full Text] [Related]
36. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
Remmers AE; Clark MJ; Liu XY; Medzihradsky F
J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
[TBL] [Abstract][Full Text] [Related]
37. Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection.
Hu W; Mahavadi S; Huang J; Li F; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G605-10. PubMed ID: 16675745
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
Gusovsky F
Mol Pharmacol; 1991 Nov; 40(5):633-8. PubMed ID: 1658602
[TBL] [Abstract][Full Text] [Related]
39. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
40. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
